Prevalence and characteristics of community carriage of methicillin-resistant staphylococcus aureus in malta

Journal of Epidemiology and Global Health

Volumn 3, Issue 3, 2013, Pages 165-173

  Scerri, Jeanesse ^a   Monecke, Stefan ^b   Borg, Michael A ^a  

^a MATER DEI HOSPITAL   (Malta)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Antibiotics; Colonization; MRSA; Surveillance

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLONAL VARIATION; COMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MALTA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROARRAY ANALYSIS; NONHUMAN; NOSE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR;

ANTIBIOTICS; COLONIZATION; MRSA; SURVEILLANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARRIER STATE; CROSS INFECTION; FEMALE; HUMANS; MALE; MALTA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NOSE; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84881550773     PISSN: 22106006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jegh.2013.05.003     Document Type: Article

References (26)

1. European Antimicrobial Resistance Surveillance System(EARSS). EARSS annual report 2008: On-going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa. ECDC. 2009. , accessed 30 April 2011. http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/publications/Pages/documents.aspx.
2. Emori T.G., Gaynes R.P. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 2009, 6:428-442. 10.1128/CMR.6.4.428.
3. Rybak M.J., LaPlante K.L. Community associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy 2005, 25:74-85. 10.1592/phco.25.1.74.55620.
4. Sievert D.M., Rudrik J.T., Patel J.B., Clifford McDonald L., Wilkins M.J., Hageman J.C. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 2008, 46:668-674. 10.1086/527392.
5. Salgado C.D., Farr B.M., Calfee D.P. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003, 36:131-139. 10.1086/345436.
6. Herold B.C., Immergluck L.C., Maranan M.C., Lauderdale D.S., Gaskin R.E., Boyle-Vavra S., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998, 279:593-598. 10.1001/jama.279.8.593.
7. Centers for Disease Control and Prevention (CDC). Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. Morb Mortal Wkly Rep. 1999; 48:707-10.
8. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis 2001, 7:178-182.
9. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., et al. Comparison of community- and healthcare-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984. 10.1001/jama.290.22.2976.
10. Ma X.X., Ito T., Tiensasitorn C., Jamklang M., Chongtrakool P., Boyle-Vavra S., et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2002, 46:1147-1152. 10.1128/AAC.46.4.1147-1152.2002.
11. Ito T., Ma X.X., Takeuchi F., Okuma K., Yuzawa H., Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004, 48:2637-2651. 10.1128/AAC.48.7.2637-2651.2004.
12. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003, 9:978-984. 10.3201/eid0908.030089.
13. CDC. Community-associated MRSA information for clinicians. CDC. 2005. , accessed 28 April 2011. http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca_clinicians.html#7.
14. Monecke S., Slickers P., Ehricht R. Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol Med Microbiol 2008, 53:237-251. 10.1111/j.1574-695X.2008.00426.x.
15. Monecke S., Coombs G., Shore A.C., Coleman D.C., Akpaka P., Borg M.A., et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistantStaphylococcus aureus. PLoS One 2001, 6:e17936. 10.1371/journal.pone.0017936.
16. Abudu L., Blair I., Fraise A., Cheng K.K. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect 2001, 126:351-356.
17. Karapsias S, Piperaki ET, Spiliopoulou I, Katsanis G, Tseleni-Kotsovili A. Methicillin-resistant Staphylococcus aureus nasal carriage among healthy employees of the Hellenic Air Force. Euro Surveill. 2008; 13. pii: 18999.
18. Kuehnert M.J., Kruszon-Moran D., Hill H.A., McQuillan G., McAllister S.K., Fosheim G., et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006, 193:172-179. 10.1086/499632.
19. Lu P.L., Chin L.C., Peng C.F., Chiang Y.H., Chen T.P., Ma L., Siu L.K. Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage. J Clin Microbiol 2005, 43:132-139. 10.1128/JCM.43.1.132-139.2005.
20. Lee S., Park Y.J., Yoo J.H., Kahng J., Jeong I.H., Kwon Y.M., et al. Comparison of culture screening protocols for methicillin-resistant Staphylococcus aureus (MRSA) using a chromogenic agar (MRSA-Select). Ann Clin Lab Sci 2008, 38:254-257.
21. Gorwitz R.J., Kruszon-Moran D., McAllister S.K., McQuillan G., McDougal L.K., Fosheim G.E., et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008, 197:1226-1234.
22. Kenner J., O'Connor T., Piantanida N., Fishbain J., Eberly B., Viscount H., et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003, 24:439-444. 10.1086/502229.
23. Jernigan J.A., Pullen A.L., Flowers L., Bell M., Jarvis W.R. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission. Infect Control Hosp Epidemiol 2003, 24:409-414. 10.1086/502230.
24. CDC. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants - Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. Morb Mortal Wkly Rep. 2003; 52:793-5.
25. Scicluna E.A., Shore A.C., Thürmer A., Ehricht R., Slickers P., Borg M.A., et al. Characterisation of MRSA from Malta and the description of a Maltese epidemic MRSA strain. Eur J Clin Microbiol Infect Dis 2010, 29:163-170. 10.1007/s10096-009-0834-1.
26. Tsakris A., Papadimitriou E., Douboyas J., Stylianopoulou F., Manolis E. Emergence of vancomycin-intermediate Staphylococcus aureus and S. Sciuri, Greece. Emerg Infect Dis 2002, 8:536-537. 10.3201/eid0805.010387.